{"count": 6, "results": [{"_id": "37185294", "pmid": 37185294, "pmcid": "PMC10198605", "title": "A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)", "journal": "eNeuro", "authors": ["Dyson A", "Ryan M", "Garg S", "Evans DG", "Baines RA"], "date": "2023-05-16T00:00:00Z", "doi": "10.1523/ENEURO.0461-22.2023", "meta_date_publication": "2023 May", "meta_volume": "10", "meta_issue": "5", "meta_pages": "", "score": 50244.26, "text_hl": "\"We did not examine the possibility of a combinatorial effect of the compounds on @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@tactile hypersensitivity@@@, such that administering both @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_BMS204352 @CHEMICAL_MESH:C424388 @@@BMS-204352@@@ simultaneously results in a stronger phenotypic rescue. ", "citations": {"NLM": "Dyson A, Ryan M, Garg S, Evans DG, Baines RA. A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD) eNeuro. 2023 May;10(5):. PMID: 37185294", "BibTeX": "@article{37185294, title={A Targeted, Low-Throughput Compound Screen in a Drosophila Model of Neurofibromatosis Type 1 Identifies Simvastatin and BMS-204352 as Potential Therapies for Autism Spectrum Disorder (ASD)}, author={Dyson A and Ryan M and Garg S and Evans DG and Baines RA}, journal={eNeuro}, volume={10}, number={5}}"}}, {"_id": "17169357", "pmid": 17169357, "title": "Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.", "journal": "Eur J Pharmacol", "authors": ["Kim DY", "Ryu SY", "Lim JE", "Lee YS", "Ro JY"], "date": "2007-02-14T00:00:00Z", "doi": "10.1016/j.ejphar.2006.11.027", "meta_date_publication": "2007 Feb 14", "meta_volume": "557", "meta_issue": "1", "meta_pages": "76-86", "score": 50062.23, "text_hl": "Anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ mechanism of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_10090 @@@mouse@@@ @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergic@@@ @DISEASE_Asthma @DISEASE_MESH:D001249 @@@asthma@@@ model.", "citations": {"NLM": "Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol. 2007 Feb 14;557(1):76-86. PMID: 17169357", "BibTeX": "@article{17169357, title={Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model.}, author={Kim DY and Ryu SY and Lim JE and Lee YS and Ro JY}, journal={Eur J Pharmacol}, volume={557}, number={1}, pages={76-86}}"}}, {"_id": "14978092", "pmid": 14978092, "title": "A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma.", "journal": "J Immunol", "authors": ["McKay A", "Leung BP", "McInnes IB", "Thomson NC", "Liew FY"], "date": "2004-03-01T00:00:00Z", "doi": "10.4049/jimmunol.172.5.2903", "meta_date_publication": "2004 Mar 1", "meta_volume": "172", "meta_issue": "5", "meta_pages": "2903-8", "score": 50060.195, "text_hl": "A novel anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ role of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in a @SPECIES_10090 @@@murine@@@ model of @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergic@@@ @DISEASE_Asthma @DISEASE_MESH:D001249 @@@asthma@@@.", "citations": {"NLM": "McKay A, Leung BP, McInnes IB, Thomson NC, Liew FY. A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma. J Immunol. 2004 Mar 1;172(5):2903-8. PMID: 14978092", "BibTeX": "@article{14978092, title={A novel anti-inflammatory role of simvastatin in a murine model of allergic asthma.}, author={McKay A and Leung BP and McInnes IB and Thomson NC and Liew FY}, journal={J Immunol}, volume={172}, number={5}, pages={2903-8}}"}}, {"_id": "21075647", "pmid": 21075647, "title": "Effects of simvastatin on pulmonary C-fiber sensitivity in rats with monocrotaline-induced pulmonary hypertension.", "journal": "J Heart Lung Transplant", "authors": ["Hsu HH", "Ruan T", "Ko WJ", "Hsu JY", "Chen JS", "Lee YC", "Lai IR", "Chen CF"], "date": "2011-03-01T00:00:00Z", "doi": "10.1016/j.healun.2010.09.011", "meta_date_publication": "2011 Mar", "meta_volume": "30", "meta_issue": "3", "meta_pages": "332-40", "score": 50050.0, "text_hl": "CONCLUSION: @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment in @CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@MCT@@@-@DISEASE_Hypertension_Pulmonary @DISEASE_MESH:D006976 @@@PH@@@ @SPECIES_10116 @@@rats@@@ not only attenuated @DISEASE_Hypertension_Pulmonary @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@, but also desensitized @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@PCF hypersensitivity@@@ and decreased the production of @CHEMICAL_Reactive_Oxygen_Species @CHEMICAL_MESH:D017382 @@@ROS@@@. ", "citations": {"NLM": "Hsu HH, Ruan T, Ko WJ, Hsu JY, Chen JS, Lee YC, Lai IR, Chen CF. Effects of simvastatin on pulmonary C-fiber sensitivity in rats with monocrotaline-induced pulmonary hypertension. J Heart Lung Transplant. 2011 Mar;30(3):332-40. PMID: 21075647", "BibTeX": "@article{21075647, title={Effects of simvastatin on pulmonary C-fiber sensitivity in rats with monocrotaline-induced pulmonary hypertension.}, author={Hsu HH and Ruan T and Ko WJ and Hsu JY and Chen JS and Lee YC and Lai IR and Chen CF}, journal={J Heart Lung Transplant}, volume={30}, number={3}, pages={332-40}}"}}, {"_id": "27275740", "pmid": 27275740, "pmcid": "PMC4898827", "title": "Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils", "journal": "PLoS One", "authors": ["Fu CH", "Tsai WC", "Lee TJ", "Huang CC", "Chang PH", "Su Pang JH"], "date": "2016-06-08T00:00:00Z", "doi": "10.1371/journal.pone.0157186", "meta_date_publication": "2016", "meta_volume": "11", "meta_issue": "6", "meta_pages": "e0157186", "score": 50049.203, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, a @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ lowering agent, has been shown to exhibit anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ and anti-@<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergic@@@ effects. ", "citations": {"NLM": "Fu CH, Tsai WC, Lee TJ, Huang CC, Chang PH, Su Pang JH. Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils PLoS One. 2016;11(6):e0157186. PMID: 27275740", "BibTeX": "@article{27275740, title={Simvastatin Inhibits IL-5-Induced Chemotaxis and CCR3 Expression of HL-60-Derived and Human Primary Eosinophils}, author={Fu CH and Tsai WC and Lee TJ and Huang CC and Chang PH and Su Pang JH}, journal={PLoS One}, volume={11}, number={6}, pages={e0157186}}"}}, {"_id": "19539078", "pmid": 19539078, "title": "Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).", "journal": "Am J Cardiol", "authors": ["Robinson JG", "Ballantyne CM", "Grundy SM", "Hsueh WA", "Parving HH", "Rosen JB", "Adewale AJ", "Polis AB", "Tomassini JE", "Tershakovec AM"], "date": "2009-06-15T00:00:00Z", "doi": "10.1016/j.amjcard.2009.05.003", "meta_date_publication": "2009 Jun 15", "meta_volume": "103", "meta_issue": "12", "meta_pages": "1694-702", "score": 50042.51, "text_hl": "The incidence of @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver, muscle, and gastrointestinal@@@-, @DISEASE_Chemical_and_Drug_Induced_Liver_Injury @DISEASE_MESH:D056486 @@@hepatitis@@@- and @<m>DISEASE_Drug_Hypersensitivity</m> @DISEASE_MESH:D004342 @@@allergic reaction@@@/@DISEASE_Exanthema @DISEASE_MESH:D005076 @@@rash@@@-related adverse events were low and generally similar to those in previous studies of @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and/or @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@. ", "citations": {"NLM": "Robinson JG, Ballantyne CM, Grundy SM, Hsueh WA, Parving HH, Rosen JB, Adewale AJ, Polis AB, Tomassini JE, Tershakovec AM. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). Am J Cardiol. 2009 Jun 15;103(12):1694-702. PMID: 19539078", "BibTeX": "@article{19539078, title={Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).}, author={Robinson JG and Ballantyne CM and Grundy SM and Hsueh WA and Parving HH and Rosen JB and Adewale AJ and Polis AB and Tomassini JE and Tershakovec AM}, journal={Am J Cardiol}, volume={103}, number={12}, pages={1694-702}}"}}]}